Hurley Capital
IGC icon

Hurley Capital’s IGC Pharma IGC Stock Holding History

Hurley Capital’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27 Hold
100
– – ﹤0.01% 654
2026
Q2 		$27 Hold
100
– – ﹤0.01% 670
2026
Q1 		$26 Hold
100
– – ﹤0.01% 658
2025
Q4 		$28 Hold
100
– – ﹤0.01% 586
2025
Q3 		$42 Hold
100
– – ﹤0.01% 684
2025
Q2 		$31 Hold
100
– – ﹤0.01% 459
2025
Q1 		$29 Hold
100
– – ﹤0.01% 495
2024
Q4 		$36 Buy
+100
New +$37 ﹤0.01% 401

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Schneider Downs Wealth Management Advisors
Schneider Downs Wealth Management Advisors Pittsburgh, Pennsylvania $1.08B AUM 10.9% 1-Year Est. Return
Wealthcare Advisory Partners
Wealthcare Advisory Partners West Chester, Pennsylvania $5.9B AUM 14.62% 1-Year Est. Return
Geneos Wealth Management
Geneos Wealth Management Englewood, Colorado $5.32B AUM 16.49% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Hurley Capital's IGC Position: Q3 2026 in Review

Hurley Capital held its IGC Pharma (IGC) position steady in Q3 2026 at 100 shares worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Hurley Capital first reported a position in IGC in Q4 2024 and has held it in 8 quarters since. The position peaked at $42 in Q3 2025. 12 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

  • Hurley Capital held 100 shares of IGC Pharma worth $27 as of Q3 2026.
  • Hurley Capital left its IGC Pharma share count unchanged in Q3 2026.
  • IGC Pharma made up ﹤0.01% of Hurley Capital's portfolio in Q3 2026, its #654 holding.
  • Hurley Capital first reported a position in IGC Pharma in Q4 2024 and has held it in 8 quarters since.
  • Hurley Capital's IGC Pharma position peaked at $42 in Q3 2025.
  • 12 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.